Joeri Aerts

Onderzoeksresultaten per jaar

Filter

2019
Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy
iHIVARNA consortium, de Jong, W., Aerts, J., Allard, S., Brander, C., Buyze, J., Florence, E., van Gorp, E., Vanham, G., Leal, L., Mothe, B., Thielemans, K., Plana, M., Garcia, F. & Gruters, R., 13 dec 2019, In: Trials. 20, 1, 721.
Onderzoeksoutput: Comment/debate
5 Citaten (Scopus)
2014

Corrigendum to 'A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption' [Clin. Immunol. 142 (2012) 252-268]
Allard, S. D., De Keersmaecker, B., de Goede, A. L., Verschuren, E. J., Koetsveld, J., Reedijk, M. L., Wylock, C., De Bel, A. V., Vandeloo, J., Pistoor, F., Heirman, C., Beyer, W. E. P., Eilers, P. H. C., Corthals, J., Padmos, I., Thielemans, K., Osterhaus, A. D. M. E., Lacor, P., van der Ende, M. E., Aerts, J. L. & 2 anderen, van Baalen, C. A. & Gruters, R. A., 1 jan 2014, In: Clinical Immunology. 150, 1, blz. 88-89 2 blz.
Onderzoeksoutput: Comment/debate

Onderzoeksoutput